Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 3
1992 2
1995 2
2003 1
2004 2
2005 2
2006 3
2007 2
2008 5
2009 3
2010 2
2011 3
2012 3
2014 6
2015 9
2016 7
2017 14
2018 8
2019 3
2020 5
2021 7
2022 7
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, van Laar JM, Spotswood H, Wagner B, Siegel J, Jahreis A, Denton CP; focuSSced investigators. Khanna D, et al. Lancet Respir Med. 2020 Oct;8(10):963-974. doi: 10.1016/S2213-2600(20)30318-0. Epub 2020 Aug 28. Lancet Respir Med. 2020. PMID: 32866440 Clinical Trial.
[Scleroderma].
Fonollosa Pla V, Simeón Aznar CP. Fonollosa Pla V, et al. Among authors: simeon aznar cp. Med Clin (Barc). 2004 Mar 27;122(11):418-9. doi: 10.1016/s0025-7753(04)74258-x. Med Clin (Barc). 2004. PMID: 15066250 Spanish. No abstract available.
Immunoglobulins in systemic sclerosis management. A large multicenter experience.
Tandaipan J, Guillén-Del-Castillo A, Simeón-Aznar CP, Carreira PE, De la Puente C, Narváez J, Lluch J, Rubio-Rivas M, Alegre-Sancho JJ, Bonilla G, Moriano C, Casafont-Sole I, García-Vicuña R, Ortiz-Santamaría V, Riera E, Atienza-Mateo B, Blanco R, Galisteo C, Gonzalez-Martin JJ, Pego-Reigosa JM, Pros A, Heredia S, Castellví I. Tandaipan J, et al. Among authors: simeon aznar cp. Autoimmun Rev. 2023 Nov;22(11):103441. doi: 10.1016/j.autrev.2023.103441. Epub 2023 Sep 12. Autoimmun Rev. 2023. PMID: 37708984 Review.
[Raynaud's phenomenon].
Tolosa Vilella C, Simeón Aznar CP, Gabarró Julià L. Tolosa Vilella C, et al. Among authors: simeon aznar cp. Med Clin (Barc). 2009 May 16;132(18):712-8. doi: 10.1016/j.medcli.2008.11.017. Epub 2009 Mar 6. Med Clin (Barc). 2009. PMID: 19268319 Free article. Review. Spanish.
Identifying the risk of cancer-associated systemic sclerosis.
Guillen-Del-Castillo A, Simeón-Aznar CP. Guillen-Del-Castillo A, et al. Among authors: simeon aznar cp. Joint Bone Spine. 2023 Dec;90(6):105618. doi: 10.1016/j.jbspin.2023.105618. Epub 2023 Jul 22. Joint Bone Spine. 2023. PMID: 37482176 No abstract available.
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region.
Lescoat A, Huscher D, Schoof N, Airò P, de Vries-Bouwstra J, Riemekasten G, Hachulla E, Doria A, Rosato E, Hunzelmann N, Montecucco C, Gabrielli A, Hoffmann-Vold AM, Distler O, Ben Shimol J, Cutolo M, Allanore Y; EUSTAR collaborators. Lescoat A, et al. Rheumatology (Oxford). 2023 Jun 1;62(6):2178-2188. doi: 10.1093/rheumatology/keac576. Rheumatology (Oxford). 2023. PMID: 36222557
Pathogenic autoantibody internalization in myositis.
Pinal-Fernandez I, Muñoz-Braceras S, Casal-Dominguez M, Pak K, Torres-Ruiz J, Musai J, Dell'Orso S, Naz F, Islam S, Gutierrez-Cruz G, Cano MD, Matas-Garcia A, Padrosa J, Tobías-Baraja E, Garrabou G, Aldecoa I, Espinosa G, Simeon-Aznar CP, Guillen-Del-Castillo A, Gil-Vila A, Trallero-Araguas E, Christopher-Stine L, Lloyd TE, Liewluck T, Naddaf E, Stenzel W, Greenberg SA, Grau JM, Selva-O'Callaghan A, Milisenda JC, Mammen AL. Pinal-Fernandez I, et al. Among authors: simeon aznar cp. medRxiv [Preprint]. 2024 Jan 17:2024.01.15.24301339. doi: 10.1101/2024.01.15.24301339. medRxiv. 2024. PMID: 38313303 Free PMC article. Preprint.
Anti-U11/U12 Antibodies as a Rare but Important Biomarker in Patients with Systemic Sclerosis: A Narrative Review.
Fritzler MJ, Bentow C, Beretta L, Palterer B, Perurena-Prieto J, Sanz-Martínez MT, Guillen-Del-Castillo A, Marín A, Fonollosa-Pla V, Callejas-Moraga E, Simeón-Aznar CP, Mahler M. Fritzler MJ, et al. Among authors: simeon aznar cp. Diagnostics (Basel). 2023 Mar 27;13(7):1257. doi: 10.3390/diagnostics13071257. Diagnostics (Basel). 2023. PMID: 37046475 Free PMC article. Review.
Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort.
Colalillo A, Pellicano C, Ananyeva LP, Hachulla E, Cuomo G, Györfi AH, Czirják L, de Vries-Bouwstra J, Mouthon L, Poormoghim H, Del Galdo F, Hunzelmann N, Spierings J, Kuwana M, Rosato E; and the EUSTAR Collaborators. Colalillo A, et al. Arthritis Care Res (Hoboken). 2023 Jul 17. doi: 10.1002/acr.25196. Online ahead of print. Arthritis Care Res (Hoboken). 2023. PMID: 37458105 Free article.
98 results